Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.

Crowd of people blurred image

The alternative approach to clinical practice, published in The Lancet Psychiatry, was developed by health practitioners and suicide prevention experts, together with a service user.

The new guidance is intended to reduce risk through a person-centred strategy in which assessment is regarded as a therapeutic process which is aimed at identifying interventions to enhance well-being, together with an individualised safety plan developed collaboratively with the patient.

Professor Keith Hawton CBE, Professor of Psychiatry and Director of the Centre for Suicide Research at Oxford University, and a lead author on the article, said:

'A substantial proportion of individuals who die by suicide each year have been suffering from mental illness. Therefore prevention of suicide is one key task of mental health practitioners, but traditionally this has been dominated by attempts to predict suicide risk. Our approach, which is more focussed on a therapeutic approach to addressing risk, should greatly improve patient care, with likely benefits for suicide prevention.'

Karen Lascelles, Nurse Consultant at Oxford Health NHS Foundation Trust, and joint lead author of the article, said:

 

'This therapeutic and collaborative approach to patient safety can help clinicians, patients and patients' families gain a better understanding of when and why a patient might become vulnerable, and what the patient and those involved in their care can do to help keep them safe. It should be taught to clinicians during their training and in practice, and supported by organisations and regulators.'

Steve Gilbert, OBE, another author of the article, said:

 

'As a suicide attempt survivor of multiple episodes, I know all too well the heart-breaking agony of being told you are at "low risk of suicide" based on the risk prediction methodology. The importance of a clinician meeting me where I am, acknowledging my situation, and working with me to understand the ways in which we can collectively keep me safe cannot be underestimated. I believe that a therapeutic and empathetic assessment can be the starting point for a life-saving relationship.'

The authors highlight the fact that extensive evidence from several countries shows that prediction of risk largely doesn't work. They also point out that preoccupation with risk prediction may undermine efforts to help patients with their problems, which has been highlighted by both family members and patients themselves.

The full paper, Assessment of suicide risk in mental health practice: Shifting from prediction to therapeutic assessment, formulation and risk management, can be read in The Lancet Psychiatry.

Similar stories

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.